Showing results 1 to 20 of 22
next >
| Issue Date | Title | Author(s) |
| 12-Jul-2017 | BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases | Papathanassiu, AE; Ko, JH; Imprialou, M; Bagnati, M; Srivastava, PK, et al |
| 30-Jun-2017 | Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy | Medjeral-Thomas, NR; Lomax-Browne, HJ; Beckwith, H; Willicombe, M; McLean, AG, et al |
| Apr-2019 | Complement activity influences glomerular inflammation and clinical severity in IgA nephropathy and C3 glomerulopathy | Pickering, Matthew; Cook, Herbert Terence; Medjeral-Thomas, Nicholas; |
| 3-Feb-2016 | Complement receptor 3 mediates renal protection in experimental C3 glomerulopathy | Barbour, TD; Ling, GS; Ruseva, MM; Fossati-Jimack, L; Cook, HT, et al |
| 1-May-2018 | Epoxygenase inactivation exacerbates diet and aging-associated metabolic dysfunction resulting from impaired adipogenesis | Olona, A; Terra, X; Ko, JH; Grau-Bove, C; Pinent, M, et al |
| 3-Mar-2022 | Glomerulonephritis and autoimmune vasculitis are independent of P2RX7 but may depend on alternative inflammasome pathways. | Prendecki, M; McAdoo, SP; Turner-Stokes, T; Garcia-Diaz, A; Orriss, I, et al |
| 13-Jul-2016 | Identification of a nutrient sensing transcriptional network in monocytes by using inbred rat models of cafeteria diet | Martinez-Micaelo, N; Gonzalez-Abuin, N; Terra, X; Ardevol, A; Pinent, M, et al |
| 7-Jun-2017 | Identification of ceruloplasmin as a gene that affects susceptibility to glomerulonephritis through macrophage function | Chen, T; Rotival, M; Behmoaras, JV; Chiu, LY; Bagnati, M, et al |
| 28-Feb-2022 | Inhibition of spleen tyrosine kinase decreases donor specific antibody levels in a rat model of sensitization | Tempest-Roe, S; Prendecki, M; McAdoo, S; Tanna, A; Turner-Stokes, T, et al |
| Dec-2023 | Kidney transplantation in older people: impact of frailty on outcomes | Willicombe, Michelle; Brown, Edwina; Thind, Amarpreet; |
| 1-May-2016 | Partial complement factor H deficiency associates with C3 glomerulopathy and thrombotic microangiopathy | Vernon, KA; Ruseva, MM; Cook, HT; Botto, M; Malik, TH, et al |
| 13-Aug-2022 | Prevalence of frailty and cognitive impairment in older transplant candidates. A preview to the Kidney Transplantation in Older People (KTOP): impact of frailty on outcomes study | Thind, A; Goodall, D; Rule, A; Levy, S; Brice, S, et al |
| 12-Apr-2018 | Primary IgA nephropathy: current challenges and future prospects | Penfold, R; Prendecki, M; McAdoo, S; Tam, FWK; , et al |
| 14-Mar-2018 | RIPK3-deficient mice were not protected from nephrotoxic nephritis | Hill, NR; Cook, T; Pusey, C; Tarzi, R; |
| Apr-2015 | The role of complement iC3b in dense deposit disease | Pickering, Matthew; Botto, Marina; Barbour, Thomas David; |
| Oct-2013 | The role of local complement factor H production in complement-mediated renal disease | Pickering, Matthew; Botto, Marina; Vernon, Katherine Anne; |
| 30-Jul-2016 | Spleen tyrosine kinase: a crucial player and potential therapeutic target in renal disease | Tam, FWK; Ma, TK-W; Mcadoo, SP; McAdoo, SPM; Ma, TK-M, et al |
| 20-Jan-2017 | Targeting the tyrosine kinase signaling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond | Ma, TK-W; McAdoo, SP; Tam, FWK; , et al |
| 1-Sep-2017 | The Endless Summer Thermoneutrality Prevents Monocytosis and Reduces Atherosclerosis | Woollard, KJ; Murphy, AJ; |
| Sep-2018 | The role of the spleen tyrosine kinase pathway in driving inflammation in IgA nephropathy | Tam, FWK; McAdoo, S; , et al |